The IKEA Foundation Pledges More Than €11 Million in Emergency Humanitarian Aid for Sudan
8.6.2023 13:23:00 EEST | Business Wire | Press release
The IKEA Foundation has donated €5 million to Médecins Sans Frontières - Doctors Without Borders (MSF) to provide urgent medical care and supplies to people affected by the recent fighting in Sudan. It has also donated €6.7 million to Better Shelter to deploy 3,000 units to meet the immediate shelter needs of people displaced by the deadly conflict.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005375/en/
Illustration of fighting in Khartoum, Sudan Copyright: MSF/Atsuhiko Ochiai Countries: Sudan Date taken / Date Recorded: 04 May, 2023 Caption / Description: Aerial view captures the fighting and violence that erupted in Khartoum, Sudan. (Photo: Business Wire)
Intense fighting broke out in Khartoum, Sudan on 15 April and has since spread to other parts of the country. Local hospitals have been overwhelmed as people arrive with serious injuries caused by gunshots, explosions and airstrikes. The country’s health system, which has been struggling for decades, is facing a huge increase in needs and a shortage of supplies.
Within Sudan, many of those forced to flee are arriving in overcrowded urban areas already hosting internally displaced people. Sudan is also hosting more than one million refugees who have fled violence in neighbouring countries. This is placing immense strain on overstretched resources and exposing vulnerable people to risks such as evictions, family separation and gender-based violence.
Per Heggenes, CEO of the IKEA Foundation, said: “The violence in Sudan is a devastating human tragedy. It is our responsibility to alleviate the suffering of those caught in the crossfire. We strongly urge other funders to join us in delivering life-saving humanitarian assistance to Sudan. Let’s come together and make a tangible difference in the lives of those devastated by the conflict”
Urgent life-saving care by MSF
The IKEA Foundation’s donation will help MSF provide life-saving care both through medical interventions and by distributing supplies. It will also contribute to supporting MSF's activities across 10 states in Sudan. MSF teams have been treating war wounded, providing healthcare services and supplies, and water and sanitation.
Stephen Cornish – Director General – Médecins Sans Frontières (MSF) – Geneva Operational Centre said: “As the conflict in Sudan spirals into its second month and humanitarian needs outstrip response capacity, IKEA Foundation’s backing of our medical work across the country marks a collective resolution to take all possible measures to support those caught in the violence.
“The contribution is a testament to the determination and professionalism of our teams on the ground, who despite the many challenges and obstacles remain committed to extending life-saving healthcare. We are deeply thankful for the steadfast support of the IKEA Foundation. Today’s donation of €5 million will go a long way in helping us to provide humanitarian and medical aid to those most affected by the ongoing crisis.”
Immediate shelter needs by Better Shelter
An estimated 1.4 million Sudanese people have been displaced by this conflict already. This includes people fleeing internally and those crossing borders into neighbouring countries, including Chad and Ethiopia. Food, shelter, and protection services are among people’s urgent needs. To meet the immediate need for shelter as expressed by UNHCR, the UN Refugee Agency, Better Shelter will deploy 3,000 units immediately to neighbouring countries.
Johan Mast, Acting Manager Director, Better Shelter, said: “The current situation in Sudan is alarming. Millions of people are experiencing insecurity, food and water scarcity, and various challenges that require urgent attention. We are very grateful for the IKEA Foundation stepping in to assist and pleased to offer shelter to 15,000 individuals affected by the crisis. Shelter is a fundamental human need that provides physical protection and helps with emotional healing and recovery from the traumatic experiences they have endured.”
About the IKEA Foundation
The IKEA Foundation is a strategic philanthropy that focuses its grant making efforts on tackling the two biggest threats to children’s futures: poverty and climate change. It currently grants more than €200 million per year to help improve family incomes and quality of life while protecting the planet from climate change. Since 2009, the IKEA Foundation has granted more than €1.8 billion to create a better future for children and their families.
In 2021 the Board of the IKEA Foundation decided to make an additional €1 billion available over the next five years to accelerate the reduction of Greenhouse Gas emissions.
When an emergency strikes, time is of the essence. To provide the most efficient response, the IKEA Foundation provides extraordinary emergency funding to a select few partner organisations, who work mainly in Africa, Asia and the Middle East. In 2023 we have provided more than €31 Million in emergency funding.
About Médecins Sans Frontières
Médecins Sans Frontières (MSF) translates to Doctors without Borders, is a non-profit, self-governed, member-based organisation. MSF provides medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. MSF teams are made up of tens of thousands of health professionals, logistic and administrative staff. Their actions are guided by medical ethics and the principles of impartiality, independence and neutrality.
Since 1978, as a first-hand witness and responder to the dire needs of the Sudanese people, MSF has mobilised teams across 12 states, implemented around 20 projects from primary and secondary healthcare, mobile clinics, nutrition, reproductive and mental healthcare to vaccination, health promotion, and water and sanitation.
About Better Shelter
Better Shelter is a humanitarian non-profit organisation based in Sweden. It started developing temporary shelters more than ten years ago, with a big mission dedicated to sheltering displaced persons with safety, dignity and hope on their path towards a more stable life in a permanent home of their own. While its work has grown in scale, the small team continues to support partners and deliver shelters internationally from warehouses in Poland, Türkiye, and Panama.
Since 2015, Better Shelter has delivered more than 85,000 shelters to emergency, crisis, and development programs in over 80 countries. Better Shelter has impacted the lives of hundreds of thousands of displaced persons through collaborations with humanitarian NGOs and INGOs, UN bodies, philanthropic foundations, and academic institutions, including the UN Refugee Agency, UNHCR, the IKEA Foundation and the Aga Khan Agency for Habitat. www.bettershelter.org
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005375/en/
Contact information
Lotika Mehta, lotika.mehta@ikeafoundation.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
